Relationship between High Resolution CT Chest and Laboratory Parameters- An Assessment Tool for the Safe and Timely Management of Suspected/Confirmed Covid-19 Disease Patients

  • Sanum Kashif Frontier Corps Hospital, Quetta
  • Erum Pervaiz Frontier Corps Hospital, Quetta
Keywords: COVID-19, CO-RADS Score, High Resolution CT Chest, Laboratory Parameters.

Abstract

Objective: To assess the relationship between radiological findings and laboratory parameters, for safe and
timely management of COVID-19 disease patients.
Study Design: Retrospective observational study.
Place and Duration of Study: The study was conducted at COVID-19 isolation ward of Frontier Corps Hospital, Quetta, from April 15th to June 30th, 2020.
Materials and Methods: Suspected COVID-19 (on the basis of history) patients, from April 15th to June 30th ,
2020, were included in the study. Laboratory parameters including, Neutrophils, Lymphocytes, C-Reactive
Protein (CRP) were retrospectively collected from medical records. Severity of lung changes on high resolution
chest CT was scored according to the lung involvement (CO-RADS score 1-6). Spearman rank correlation was
used to evaluate the relationship between CO-RADS score and laboratory parameters.
Results: A total of 50 patients (mean age 34.7+6.46 years [standard deviation]; age range, 23-49 years) were
evaluated. The patients underwent a total of 150 CT scans chest. CO-RADS was significantly co-related with
neutrophils count at day 1 (r=0.93, p-value < 0.001), day 5 (r=0.47, p-value=0.001), day 14 (r=0.94, p value<
0.001), lymphocytes count at day 1 (r=0.15, p-value<0.001), day 5 (r=0.90, p-value<0.001), day 14
(r=0.83, p-value=0.004), CRP at day 1 (r=0.90, p-value=0.001), day 5 (r=0.36, p-value=0.011) and at day 14
(r=0.93, p-value=0.001).
Conclusion: The results of this study showed that the severity of lung involvement on high resolution CT (HRCT) chest positively correlate with laboratory parameters. The study provides an insight into the appropriate
interval of chest CT to reduce radiation and promote timely management of COVID-19 patients.

References

Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global

emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery. 2020; 76: 71-6.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of

novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507–13.

Hsu LY, Lee CC, Green JA, Ang B, Paton NI, Lee L, et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis. 2003; 9: 713–7.

Wang EA, Zenilman J, Brinkley-Rubinstein L. Clinical characteristics of 138 hospitalized patients with 2019 novel

coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 ; 324: 1031-2.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute

respiratory distress syndrome. Lancet Respir Med. 2020; 8: 420–2.

Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. A pathological report of three COVID-19 cases by minimally

invasive autopsies. Chinese journal of pathology. 2020; 49: E009.

Ortiz-Fernández L, Sawalha AH. Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations. Genes & Immunity. 2020; 21: 269-72.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727–33.

Zhang B, Zhang J, Chen H, Chen L, Chen Q, Li M, et al. Novel coronavirus disease 2019 (COVID-19): relationship

between chest CT scores and laboratory parameters. European Journal of Nuclear Medicine and Molecular

Imaging. 2020; 47: 2083-9.

Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020.

Fan BE, Chong VC, Chan SS, Lim GH, Lim KG, Tan GB, et al. Hematologic parameters in patients with COVID-19

infection. American journal of hematology. 2020; 95: E131-4.

Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A m a j o r o u t b re a k o f s eve re a c u te re s p i rato r y syndrome(SARS) in Hong Kong. N Engl J Med. 2003; 348: 1986–94.

Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, et al. Identification of severe acute respiratory syndrome (SARS) in Canada. N Engl J Med. 2003; 348: 1995–2005.

Mez J, Daneshvar DH, Kiernan PT, Abdolmohammadi B, Alvarez VE, Huber BR, et al. Epidemiologic and clinical

characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020; 318: 360-70.

Chung M, Adam B, Mei X, Zhang N, Huang M, Cui J, et al. CT Imaging Features of 2019 Novel coronavirus (2019-nCoV). Radiology. 2020; 295: 202–7.

Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools- Lartigue J, Crawford JM, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 2020;

; 295: 202–7.

Schönrich G, Raftery MJ. Neutrophil extracellular traps go viral. Front Immunol. 2016; 7: 366.

Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S, et al. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res. 2020; 21: 74.

Shi H, Han X, Zheng C. Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019- nCoV) pneumonia in Wuhan, China. Radiology. 2020; 295: 20.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368: m606.

Fang Y, Zhang H, Xu Y, Xie J, Pang P, Ji W. CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020; 295: 208-9.

Fang Y, Zhang H, Xu Y, Xie J, Pang P, Ji W. CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020; 295: 208-9.

Feng P, Tianhe Y, Peng S, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID19) pneumonia. Radiology. 2020; 13: 200370.

Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003; 361: 1319–25.

Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan-Yeung M, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348: 1977–85.

Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging coronavirus 2019-nCoV pneumonia. Radiology. 2020; 295: 210–7.

National Health and Health Commission and State Administration of traditional Chinese medicine. Diagnosis

and treatment of pneumonia caused by new coronavirus infection (Trial version 5 [J/OL]). Chinese J Integrated

Traditional Western Edicine. 2020; 40: 136-8.

Published
2021-06-29
Section
Original Article